Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
Clinical trial NCT00132002 · TERMINATED
Trial details
- NCT number
- NCT00132002
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2008-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.